OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW

Oculis Holding AG

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026

$7.32+0.03 (+0.41%)

Close on Oct 19, 2026

Oculis Holding AG revenue by segment

Oculis does not break out revenue by segment, region or product in the tagged data of its filings for this period type.